BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11443929)

  • 1. [Status of the human DNA papillomavirus in cervical tumors].
    Kiselev FL; Kiseleva NP; Kobzeva VK; Gritsko TM; Semenova LA; Pavlova LS; Klaes R; von Knebel Doeberitz M
    Mol Biol (Mosk); 2001; 35(3):470-6. PubMed ID: 11443929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of viral E2-gene status on outcome after radiotherapy for patients with human papillomavirus 16-positive cancer of the uterine cervix.
    Lindel K; de Villiers EM; Burri P; Studer U; Altermatt HJ; Greiner RH; Gruber G
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):760-5. PubMed ID: 16682151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
    Zheng Y; Peng ZL; Lou JY; Wang H
    Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence and expression of human papillomavirus type 16 genes in uterine cervical carcinomas.
    Tanimoto H
    Hiroshima J Med Sci; 1992 Dec; 41(4):71-7. PubMed ID: 1338065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up.
    Hernádi Z; Szarka K; Sápy T; Krasznai Z; Veress G; Póka R
    BJOG; 2003 Feb; 110(2):205-9. PubMed ID: 12618167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions.
    Matovina M; Sabol I; Grubisić G; Gasperov NM; Grce M
    Gynecol Oncol; 2009 Apr; 113(1):120-7. PubMed ID: 19157528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of high-risk human papillomavirus (HPV) E6 and E7 oncogene transcripts increases the specificity of the detection of a cervical intraepithelial neoplasia (CIN)].
    Sotlar K; Diemer D; Stubner A; Menton S; Menton M; Dietz K; Wallwiener D; Bültmann B
    Verh Dtsch Ges Pathol; 2005; 89():195-200. PubMed ID: 18035691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical status of HPV-16 in esophageal squamous cell carcinoma.
    Si HX; Tsao SW; Poon CS; Wong YC; Cheung AL
    J Clin Virol; 2005 Jan; 32(1):19-23. PubMed ID: 15572001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus DNA and virus-encoded antigens in cervical carcinoma.
    Padmanathan A; Yadav M; Gregory AR; Kumar S; Norhanum AW
    Med J Malaysia; 1997 Jun; 52(2):108-16. PubMed ID: 10968067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of S100P gene in cervical carcinoma cells is independent of E7 human papillomavirus oncogene.
    Jakubícková L; Baráthová M; Pastoreková S; Pastorek J; Gibadulinová A
    Acta Virol; 2005; 49(2):133-7. PubMed ID: 16047742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus DNA is present in a subset of unselected breast cancers.
    Liu Y; Klimberg VS; Andrews NR; Hicks CR; Peng H; Chiriva-Internati M; Henry-Tillman R; Hermonat PL
    J Hum Virol; 2001; 4(6):329-34. PubMed ID: 12082399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of genetic rearrangements in E1/E2 regions of episomal HPV 16 isolates from cervical carcinomas 5-8.
    Dong X; Zhou W; Pfister H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):5-8. PubMed ID: 11503015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma.
    Rosty C; Sheffer M; Tsafrir D; Stransky N; Tsafrir I; Peter M; de Crémoux P; de La Rochefordière A; Salmon R; Dorval T; Thiery JP; Couturier J; Radvanyi F; Domany E; Sastre-Garau X
    Oncogene; 2005 Oct; 24(47):7094-104. PubMed ID: 16007141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
    Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
    Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients.
    Dang C; Koehler A; Forschner T; Sehr P; Michael K; Pawlita M; Stockfleth E; Nindl I
    Br J Dermatol; 2006 Jul; 155(1):129-36. PubMed ID: 16792764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
    de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
    Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions.
    Wentzensen N; Ridder R; Klaes R; Vinokurova S; Schaefer U; Doeberitz Mv
    Oncogene; 2002 Jan; 21(3):419-26. PubMed ID: 11821954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relationship with human papilloma virus DNA in cervical adenocarcinoma].
    Ogura K; Ishi K; Suzuki F; Suto H; Kina K; Koyatsu J; Nojima M; Yoshida K; Suda K
    Rinsho Byori; 2004 Feb; 52(2):115-9. PubMed ID: 15027314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
    Jiang M; Milner J
    Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.